ARTICANZ - Beta (ver 0.91)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Results - target/anti-TIGIT-monoclonal-antibody

Search results

target/anti-TIGIT-monoclonal-antibody
10 trial(s) found.
NCT06727565
NCT06003621
NCT05676931
2450 - Coffs Harbour - Coffs Harbour Health Campus - The North Coast Cancer Institute (WITHDRAWN)
NCT05286801
NCT04929223
NCT04524871
NCT04305054
QLD4215 - Southport - Tasman Oncology (COMPLETED)
NCT04164199
NCT02861573
NCT05805501
Filters
PD-1/PD-L1
100%
TIGIT
100%
PD-1
70%
VEGF
50%
PD-L1
40%
LAG3
40%
CTLA4
20%
HIF2a
20%
KIT
20%
PARP
20%
PDGFR
20%
VEGFR
20%
CD73
10%
CDK7
10%
EGFR
10%
KRAS
10%
KRAS G12C
10%
PI3Kalpha
10%
IL-6
10%
PPAR-alpha
10%
ERBB2
10%
HPK1
10%
OX40
10%
RET
10%
VEGFR1
10%
VEGFR2
10%
VEGFR3
10%
AR
10%
CYP17A1
10%
androgen axis
10%




















 






























	
		
	

    

        

			ARTICANZ (Annotated Registry of Trials in Cancer, Australia/NZ Edition; ARTificial Intelligence-enhanced CANcer trial information database) provides information about cancer drug trials in Australia and New Zealand as a free, open-information platform. Please note the following:

			
    
			
  • Data Accuracy: While ARTICANZ strives to maintain accurate and up-to-date information through regular weekly updates and specialist review, we cannot guarantee the complete accuracy, reliability, or timeliness of all data. Information may change between updates.
    • 
			
			
  • Not Medical Advice: The information provided by ARTICANZ is for informational purposes only and should not be considered medical advice. All clinical decisions should be made in consultation with qualified healthcare professionals.
    • 
			
			
  • No Warranty: ARTICANZ is provided "as is" without any warranties, expressed or implied. We disclaim all liability for any damages arising from the use of or inability to use this platform.
    • 
			
			
  • External Links: ARTICANZ may contain links to external websites. We are not responsible for the content or privacy practices of these sites.
    • 
			
			


			By using ARTICANZ, you acknowledge that you have read and understood this disclaimer.
			
		

        

            
The ARTICANZ platform and its contents are made available under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

            
            
Users are free to:

            
    
                
  • Share — copy and redistribute the data in any medium or format
    • 
                
  • Adapt — remix, transform, and build upon the data
    • 
                
  • Use the data for any purpose, including commercial use
    • 
            

            
            
Under the following terms:

            
    
                
  • Attribution — You must give appropriate credit to ARTICANZ, provide a link to the license, and indicate if changes were made
    • 
                
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
    • 
            

            
            
Platform developed and currently maintained by Dr. Frank Lin and the ARTICANZ team.